SCHEMBL6724474

SCHEMBL6724474

COc1cc(-c2cccc3c2CCc2c-3nc(N)c3ccccc23)cc(OC)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
HPGD P15428 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 2/20 0.46
ATM Q13315 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
S1PR4 O95977 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ACHE P22303 2/20 0.45
FYN P06241 8/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MC4R P32245 1/20 0.43
DHFR P00374 1/20 0.43
PDGFRB P09619 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049426 0.71 BCHE (0.65) MAPTHPGDKDM4EALDH1A1NPSR1
SCHEMBL14527638 0.70 FYN (0.47) MAPTHPGDKDM4EALDH1A1NPSR1
Hydrochloric Acid SCHEMBL8059101 0.70 BCHE (0.63) MAPTHPGDKDM4EALDH1A1NPSR1
SCHEMBL10146654 0.69 MAPT (0.50) MAPTHPGDKDM4EALDH1A1NPSR1
SCHEMBL5172582 0.68 GAA (0.41) MAPTHPGDKDM4EALDH1A1NPSR1
SCHEMBL6974958 0.68 FYN (0.55) HPGDKDM4EALDH1A1GAASMN1; SMN2
Hydrochloric Acid SCHEMBL5172286 0.68 GAA (0.41) MAPTHPGDKDM4EALDH1A1NPSR1
SCHEMBL2232345 0.67 CYP1A1 (0.62) HPGDALDH1A1LMNAL3MBTL1GAA
SCHEMBL8022641 0.67 ACHE (0.81) KDM4EALDH1A1LMNAGAAACHE
SCHEMBL14523886 0.67 KDM4E (0.76) MAPTHPGDKDM4EALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040034051-A1 PHENANTHRIDINE DERIVATIVES AND ANTITUMORAL MEDICAMENTS CONTAINING PHENANTHRIDINE CLEMENT BERND (DE) 2004-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034051-A1 PHENANTHRIDINE DERIVATIVES AND ANTITUMORAL MEDICAMENTS CONTAINING PHENANTHRIDINE VHL, ENTPD5, SLC30A5 MAPT 3727/4885HPGD 460/4885KDM4E 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.